Alivus Life

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE03Q201024
  • NSEID: ALIVUS
  • BSEID: 543322
INR
1,434.15
-15.7 (-1.08%)
BSENSE

Nov 20

BSE+NSE Vol: 1.51 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Standalone Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 6.49% vs -7.07% in Jun 2026

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Sep 2026 is 22.91% vs -1.59% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 25.26% vs -1.31% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is 0.00% vs 0.00% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

Compare Quarterly Results Of Alivus Life With
Markets Mojo
Figures in Cr
Standalone Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
681.99
206.14
475.85
230.84%
Other Operating Income
0.00
0.00
0.00
Total Operating income
681.99
206.14
475.85
230.84%
Raw Material Cost
299.25
47.18
252.07
534.27%
Purchase of Finished goods
0.00
7.02
-7.02
-100.00%
(Increase) / Decrease In Stocks
-56.39
0.26
-56.65
-21,788.46%
Employee Cost
69.61
33.04
36.57
110.68%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
104.33
49.69
54.64
109.96%
Total Expenditure (Excl Depreciation)
416.80
137.19
279.61
203.81%
Operating Profit (PBDIT) excl Other Income
265.19
68.95
196.24
284.61%
Other Income
19.92
14.57
5.35
36.72%
Operating Profit (PBDIT)
285.11
83.52
201.59
241.37%
Interest
1.31
2.20
-0.89
-40.45%
Exceptional Items
0.00
0.88
-0.88
-100.00%
Gross Profit (PBDT)
283.80
82.20
201.60
245.26%
Depreciation
21.82
15.46
6.36
41.14%
Profit Before Tax
261.97
66.74
195.23
292.52%
Tax
65.23
16.62
48.61
292.48%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
196.75
50.12
146.63
292.56%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
196.75
50.12
146.63
292.56%
Equity Capital
24.55
19.56
4.99
25.51%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
16.03
2.56
13.47
526.17%
Diluted Earnings per share
15.98
2.56
13.42
524.22%
Operating Profit Margin (Excl OI)
38.88%
33.45%
0.00
5.43%
Gross Profit Margin
41.61%
39.88%
0.00
1.73%
PAT Margin
28.85%
24.31%
0.00
4.54%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 681.99 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 6.49% vs -7.07% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 15.99% vs 16.00% in Sep 2025

Quarterly - Standalone Net Profit
Standalone Net Profit 196.75 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 22.91% vs -1.59% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 51.31% vs 36.41% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 265.19 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 25.26% vs -1.31% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 48.01% vs 33.35% in Sep 2025

Quarterly - Interest
Interest 1.31 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 0.00% vs 0.00% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -0.76% vs 288.24% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 38.88%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025